CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 266,890 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03835780
NCT03835780N/ACompleted

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a UK Matched Cohort Study

Momentum Data·observational·Posted Feb 11, 2019·Updated Jun 11, 2025

In Brief

An observational study evaluating No intervention for Venous Thromboses and 8 related conditions. Completed, enrolled 266,890 participants across 1 site.

Detailed Summary

Blood clots occurring in the legs and in the lungs are relatively common; they occur in around 3 in a 1000 people per year. They can cause disability and are also potentially life threatening. When a clot occurs in the legs it is called a deep vein thrombosis or DVT. When they occur in the lungs they are called a pulmonary embolism or PE. The risk for DVT and PE is higher in people with conditions which cause inflammation. The most common of these are inflammatory bowel disease (ulcerative colitis and Crohn's disease), rheumatoid arthritis, and psoriatic arthritis (a condition comprised of psoriasis and joint inflammation). What is not known is how much higher the risk of DVT and PE is in these groups compared with people without inflammatory disease, and what causes the excess risk in these people. This study aims to assess the measure the exact increase in risk for DVT and PE in people with these inflammatory conditions and to identify which risk factors are most strongly associated with the increased risk. These data should help with an understand the causes of blood clot risk in these inflammatory conditions and in identify targets for reducing risk.

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 11, 2019
Enrollment StartFeb 1, 2019
Primary CompletionAug 1, 2019
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.4 years ago

Interventions

No interventionother

A observation of outcomes in usual practice